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Abstract: Although the bioactivities of bovine lactoferrin have been extensively investigated, little is
known about deer milk lactoferrin bioactivity and its amino acid sequence. This research investi-
gated the amino acid sequence of deer lactoferrin and the antimicrobial activities of two lactoferrin-
encrypted peptides; lactoferricin (Lfcin) and lactoferrampin (Lfampin). Deer lactoferrin was found
to have a molecular weight of 77.1 kDa and an isoelectric point of 7.99, which are similar to that of
bovine lactoferrin, 78 kDa and pI 7.9. Deer lactoferrin contains 707 amino acids, one amino acid less
than bovine lactoferrin, and has 92% homology with bovine lactoferrin. Deer lactoferricin exhibited
strong antimicrobial activity against E. coli American Type Culture Collection (ATCC) 25922 and
L. acidophilus ATCC 4356. The antimicrobial activities of deer and bovine Lfcin and Lfampin were
compared. Based on MIC, deer Lfcin was found to be a more effective inhibitor of L. acidophilus ATCC
4356 than bovine Lfcin, but bovine Lfcin and Lfampin were more effective against E. coli ATCC 25922
than deer Lfcin and Lfampin. The deer Lfcin sequence differed at seven amino acids from bovine
Lfcin and this decreased the net positive charge and increased the hydrophobicity. Deer Lfampin
contained two differences in amino acid sequence compared to bovine Lfampin which decreased
the net positive charge. These amino acid sequence differences likely account for differences in
antibacterial activity. Positive charge and hydrophobic residues provide the amphipathic character of
these helical peptides, and are considered important for binding of antimicrobial peptides. In silico
modelling of deer Lfcin indicated an identical α-helical structure compared to bovine Lfcin.
Keywords: deer lactoferrin amino acids; deer lactoferricin; deer lactoferrampin; antibacterial activity
1. Introduction
The extended use of antibiotics has led to antibiotic resistance which threatens global
health and food security. Antimicrobial peptides have potential as alternatives to antibi-
otics. Compared with traditional antibiotics, a typical antimicrobial peptide can have
a higher isoelectric point, better thermal stability, broader-spectrum antimicrobial proper-
ties, and can be more amenable to preparation in a sterile form [1]. It has been suggested
that antimicrobial peptides should not cause widespread resistance, due to their prefer-
ential attack on bacterial cell membranes [2]. Dairy products are an important source of
antimicrobial peptides [3]. There has been a dramatic increase in the farming of red deer
recently and emergence of deer milk dairying, hence deer milk could provide a potential
alternative source of antimicrobial peptides [4,5].
The whey protein lactoferrin (Lf), an iron-binding glycoprotein of the transferrin
family, exhibits antimicrobial properties in its intact form. Lf from bovine is the most
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studied among all species [6]. Bovine Lf is comprised of 708 amino acids with a molecular
weight of 78 Da [7]. A number of mechanisms have been suggested for the antimicrobial ac-
tivity of Lf, including iron deprivation from bacteria [8], direct interaction with pathogenic
microorganisms causing cell lysis [9], and prevention of the interaction between bacteria
and host cells [10]. Several antimicrobial peptides are reported to be encrypted in bovine
Lf. The most well-known are the two peptides, lactoferricin (Lfcin, 17–41) and lactofer-
rampin (Lfampin, 265–284). These two peptides are reported to exhibit substantial broad
spectrum activity against bacteria, yeast, fungi and parasites [11]. Bovine Lfcin derived
from the N-terminal domain of Lf (17–41) (FKCRRWQWRMKKLGAPSITCVRRAF) [12]
can be generated by in vitro digestion with pepsin at pH 3, 37 ◦C for 4 h, and was found to
display broad spectrum activity against bacteria, yeast, fungi, and parasites [13]. Bovine
Lfampin (268–284) (WKLLSKAQEKFGKMKSR), is derived from the C-terminal domain
of Lf [12]. Bovine Lfampin has been chemically synthesized and demonstrated to exhibit
candidacidal activity, and antibacterial activity against Bacillus subtilis, Escherichia coli, and
Pseudomonas aeruginosa [14].
No studies to date have been carried out investigating the amino acid sequence of
deer Lf. Analysis of the primary structure of antimicrobial peptides encrypted in proteins
such as Lf can help in understanding the mechanisms of their antimicrobial activities.
Comparison of the similarities and differences between deer Lf and bovine Lf may provide
insights into the antimicrobial activity of deer Lf and its peptides, as well as any potential
advantage of deer milk as an alternative milk product. The objectives of the present study
were to investigate the amino acid sequence of Lfcin and Lfampin in deer milk Lf, compared
to that of bovine Lf, and the antimicrobial properties of the peptides.
2. Materials and Methods
2.1. Materials
Ion exchange chromatography materials were obtained from GE Healthcare (now
Cytiva), Uppsala, Sweden. All chemicals for sodium dodecyl sulphate–polyacrylamide gel
electrophoresis (SDS-PAGE) were obtained from Bio-Rad Laboratories, Irvine, CA, USA,
unless otherwise stated. Bacterial strains used in antibacterial activity assays (Escherichia
coli ATCC 25922, Staphylococcus aureus ATCC 25923, and L. acidophilus ATCC 4356) were
from ESR (Christchurch, Canterbury, New Zealand). A LIVE/DEAD BaclightTM bacterial
viability kit (L7007) was from Molecular Probes, Eugene, OR, USA, with detection using
a fluorescence microscope (Nikon Eclipse 50i, Tokyo, Japan), were used for assay of bacterial
cell viability. Commercial bovine Lf was used for in vitro digestion and antibacterial activity
assay.
2.2. Purification of Deer Lactoferrin by Fast Protein Liquid Chromatography
Lf was enriched from deer milk using a sequential ion exchange chromatography
method [15]. Deer milk sweet whey was prepared by adding 1 mL renin solution (Renco,
Eltham, New Zealand) per litre of deer milk, incubating at 37◦C, 1 h, and the clarified
sweet whey fraction was obtained by centrifuging at 10,000× g, 15 min. Deer milk whey
was filtered (DVPP, 0.45 µm, Durapore®, Millipore, Carrigtwohill, Ireland) and the pH was
adjusted to 3.8 with 1 M HCl and initially subjected to anion exchange chromatography
using two × 5 mL HiTrap Q-FF cartridges (GE Healthcare) linked in series, equilibrated
with 20 mM sodium citrate, pH 3.8, containing 40 mM NaCl, on a FPLC (BioLogic DuoFlow,
GE Healthcare). The unbound protein fraction was collected and adjusted to pH 7.0 and
loaded onto a 5 mL HiTrap SP-FF cartridge (GE Healthcare), equilibrated in 20 mM sodium
dihydrogen phosphate, pH 7.0. Bound proteins were eluted with stepwise increase in
ionic strength using sodium dihydrogen phosphate, pH 7.0, containing (i) 0.1 M NaCl,
(ii) 0.4 M NaCl, and (iii) 1.0 M NaCl. Protein containing fractions were collected, concen-
trated, and desalted using Vivaspin®20, 10 kDa MWCO spin filter units (GE Healthcare).
Fractions were analyzed by SDS-PAGE, to confirm that the Lf eluted in the 1.0 M NaCl step.
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2.3. SDS-PAGE
Deer Lf was analyzed by SDS-PAGE on an in-house made 12% acrylamide gel run
in a Bio-Rad mini-gel electrophoresis system according to a standard protocol [16]. The
gels were made with resolving gel 1.5 M Tris (pH 8.8), stacking gel 0.5 M Tris (pH 6.8),
30% (w/v) acrylamide/bis-acrylamide (37.5:1, 2.6% C), 10% (w/v) SDS solution, using 10%
(w/v) ammonium persulfate and TEMED as catalysts. Protein samples were diluted with
sample buffer, which contained 0.23 M Tris (pH 6.8), 8% SDS, 40% (v/v) glycerol, 0.08%
(w/v) bromophenol blue and 4% (v/v) mercaptoethanol, with heating at 72°C for 10 min
prior to loading on the gel. BioRad Precision Plus ProteinTM standard (#1610373) was used
as a molecular weight marker. Electrophoresis was performed at a constant voltage of
120 V for 90 min. After electrophoresis, the gel was fixed in 50% (v/v) methanol and 7%
(v/v) acetic acid for 15 min and then washed 3 × 5 min with reverse osmosis grade water
and then stained with GelCodeTM Blue (Thermo ScientificTM, #24590, USA), according
to the supplier’s instructions. Stained SDS gels were scanned using a CS90000F Mark II
scanner (Canon, Auckland, New Zealand).
2.4. Deer Lf Amino Acid Sequence Analysis
The deer Lf band excised from a stained SDS-PAGE was subjected to an in-gel diges-
tion process, in which the gel was diced into small pieces and subjected to in-gel digestion
with sequencing grade modified trypsin (Promega, Madison, WI, USA) based on a pub-
lished method [17]. The extracted tryptic peptides were dried in a Savant Speed Vac Plus
(Savant, Hyannis, MA, USA), and then redissolved in 20–50 µL of 5% (v/v) acetonitrile,
0.2% (v/v) formic acid in Type 1 MQ-water, and aliquots were injected onto an Ultimate
3000 nano-flow uHPLC-System (Dionex, Sunnyville, CA, USA) that was in-line coupled to
the nano-spray source of an LTQ-Orbitrap XL hybrid mass spectrometer (Thermo Scientific,
San Jose, CA, USA). Peptides were separated on an in-house packed emitter-tip column
(75 µm ID PicoTip fused silica tubing of length 8–9 cm (New Objective, Woburn, MA, USA),
packed with C-18 resin, and using 0.2% (v/v) formic acid in MQ-water (buffer A) and
0.2% (v/v) formic acid in acetonitrile (buffer B), with a gradient developed from 5% (v/v)
acetonitrile, 0.2% [v/v] formic acid to 99% [v/v] acetonitrile, 0.2% [v/v] formic acid in water
at a flow rate of 400 µL/min [18].
A typical instrument setting for the LTQ-Orbitrap was full MS in a mass range between
m/z 400–2000, performed in the Orbitrap mass analyzer with a resolution of 60,000 and
an AGC target of 5e5. Preview mode for FTMS master scan was enabled to generate precur-
sor mass lists. The highest 7 signals were selected for CID (collision induced dissociation)-
MS/MS in the LTQ ion trap at a normalized collision energy of 35% using an AGC target
of 1e6 and one micro scan. Dynamic exclusion was enabled with 2 repeat counts during
90 sec and an exclusion period of 120 sec. Exclusion mass width was set to 0.01. After
the initial LC-MS analysis of the sample from SDS-PAGE, the LC-MS/MS was repeated
twice with different LC gradients (45 min method = 5–25% B over 17 min, 25–40% B over
4 min, 40–99% B over 4 min) and (60 min method = 5–25% B over 27 min, 25–40% B over
8 min, 40–99% B over 4 min), to optimize peptide fractionation and maximize the dynamic
range of peptide MS analysis by allowing for bias in hydrophobicity and complexity of the
peptides in multiple fractions.
MS/MS data were searched against a deer protein sequence database that was gen-
erated from a deer transcriptome analysis undertaken in-house in the Department of
Biochemistry, University of Otago. The Lf sequences were interrogated with the MS/MS
data obtained using the Mascot search engine [19]. The search for the data obtained from
the in-gel digest of the deer Lf protein band was set up for full tryptic peptides and a maxi-
mum 3 missed cleavage sites. The search for the data obtained from peptide fractions from
RP-HPLC was set up for non-tryptic peptides. Deamidation, oxidized methionine, and
carboxyamidomethyl cysteine, were included as variable modifications for in-gel digest
samples, and deamidation and oxidized methionine were included for in-solution HPLC
samples, with a fragment mass error of 0.4 Da and a precursor mass tolerance of 75 ppm.
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SwissProt was used to search for sequence coverage of deer Lf for tryptic, chymotryptic
and semi-chymotryptic peptides.
2.5. Three-Dimensional Structures of Deer Lfcin and Lfampin In Silico Analysis
3-D structures of the peptides Lfcin and Lfampin were simulated in PyMOL
(Schrödinger Inc., New York, NY, USA). Based on the amino acid sequences of deer
Lf, 3-D structures of deer Lfcin and Lfampin were automatically modelled in minimized
(optimized) energy form in PyMOL. The full amino acid sequences and the 3-D structure
of bovine Lf were obtained from the Protein Data Bank (PDB ID: 1BLF) [12].
2.6. Antibacterial Activity Assay for Deer Lfcin and Lfampin
Synthetic deer and bovine Lfcin and Lfampin were custom made by GL Biochem Ltd.
(Shanghai, China), according to their amino acid sequences. The commercial synthetic
peptides were desalted and of high purity (>98%) and verified using HPLC and MS. The
antibacterial activity assay for the synthetic peptides and controls was performed according
to the European Committee for Antimicrobial Susceptibility Testing Protocol [20]. Bacteria
in broth were serially diluted with broth to 5 × 105 cells/mL for E. coli and S. aureus, and
at 1.5 × 108 cells/mL for L. acidophilus. This was because L. acidophilus at a lower cell
density (105 cells/mL) could not achieve experimentally a good growth curve. A 100 µL
aliquot of bacteria in broth was transferred into each well of a 96-well plate and mixed with
100 µL peptide stock at different concentrations (15–960 µg/mL) prepared in broth. The
OD600 of the cells in the 96-well plate was obtained hourly using a plate reader during
24/48 h incubation at 37 ◦C. Minimum inhibitory concentration (MIC) was defined as the
lowest concentration of sample that caused complete inhibition of bacterial growth. It was
determined based on a change in OD of ≤ 0.05 at 600 nm during 24/48 h incubation; for
the determination of minimum bactericidal concentration (MBC), 100 µL sample was taken
from wells where no growth was detected, and spread on agar plates and incubated at
37 ◦C for 48 h for bacterial viable count. The MBC was defined as the lowest concentration
found where there was ≥ 99.9% loss of viable cells [21].
A positive antibiotic control was prepared with bacteria in 100 µL broth + 100 µL peni-
cillin (10,000 units/mL) and streptomycin (10,000 µg/mL) (GIBCO 15140, InvitrogenTM,
Waltham, MA, USA). A negative broth control was prepared with bacteria in 200 µL broth.
A further control was uninoculated broth (200 µL) to test for sterility, all assays were
performed in triplicate.
2.7. Bacterial Cell Viability by LIVE/DEAD BacLightTM Bacterial Viability Kit
To distinguish between viable and non-viable bacterial cells following incubation with
synthetic peptides, E. coli and L. acidophilus were stained using a LIVE/DEAD BacLightTM
Bacterial viability kit, according to the supplier’s instructions. Briefly, after 24 and 48 h
incubation in an antibacterial activity assay, 200 µL of solution containing bacterial cells
from wells containing synthesized peptides at minimum inhibitory concentration (MIC)
were separately transferred into a 1.5 mL microfuge tube, washed three times in sterile
0.85% (w/v) NaCl and thoroughly mixed with Component B (SYTO® 9 1.67 mM/propidium
Iodide 18.3 mM), and incubated at room temperature in the dark for 15 min. The viability of
bacteria was then observed using a Nikon Epi 50i fluorescence microscope (FM), equipped
with a UV lamp and a 100× magnification objective. The epifluorescence microscopy
counts were performed directly on the film adhered to the slide. The results were expressed
as the average number of cells per microscope field of view and calculated from counting
25 microscope fields of view. FM was set according to the manufacturer’s description
of excitation and emission profiles for the SYTO® 9 and PI stains. The SYTO® 9 green-
fluorescent nucleic acid stain labels all bacteria, and the PI red-fluorescent nucleic acid stain
only targets bacteria with damaged membrane. Using an appropriate mixture of these
two dyes, bacteria with intact cytoplasm membrane stain fluorescent green, whereas
bacteria with a damaged membrane stain fluorescent red.
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2.8. Statistical Analysis
Minitab version 17 statistical software (Minitab Inc., State College, PA, USA) was
used for data analysis. For bacterial cell viability, the mean ± SD were calculated from
25 fields from each slide. The data were subjected to one way analysis of variance
(ANOVA), followed by the Sidak correction in General Linear Model to determine the sig-
nificant differences between samples and broth control group, and intergroup comparisons,
at p < 0.05 level.
3. Results
3.1. Chromatography Fractionation and Electrophoresis of Lf from Deer Milk
The chromatogram obtained from the BioLogic DuoFlow cation exchange chromatog-
raphy, which was used to isolate Lf from deer milk, is shown in Figure 1. Deer Lf was
eluted with 20 mM sodium dihydrogen phosphate buffer, pH 7.0, containing 1.0 M NaCl,
corresponding to the third peak in Figure 1, and indicated that at pH 7, deer Lf was sub-
stantially positively charged, in requiring elevated ionic strength to be eluted from the
cation exchange resin. In Figure 2, the molecular weight of Lf from deer milk was found to
be in the vicinity of 75–80 kDa by SDS-PAGE. With an overloaded loading of the LF protein
on the SDS-PAGE, an additional protein band is evident between 20–25 kDa. Analysis of
this lower band by in-gel digest mass spectrometry did not generate an identity.
Figure 1. Fractionation of lactoferrin (Lf) from deer milk using cation exchange fast protein liquid chromatography (FPLC).
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Figure 2. Sodium dodecyl sulfate-polyacrylamide acrylamide gel electrophoresis (SDS-PAGE) of
lactoferrin (Lf) obtained by cation exchange chromatography from deer milk. Both lanes 1 and 2 are
Lf isolated from deer milk.
The unbound deer whey protein fraction (20 mL) obtained from the first chromatogra-
phy FPLC step was adjusted to pH 7.0 and applied to a HiTrap SP-FF 5 × 5 mL cartridge
equilibrated in 20 mM sodium dihydrogen phosphate at pH 7.0, at a flow rate of 5 mL/min.
The Lf protein was eluted with 20 mM sodium dihydrogen phosphate, pH 7.0, containing
1 M NaCl.
3.2. Amino Acid Sequence of Deer Lactoferrin
The identification of the deer Lf obtained by chromatography was confirmed by in-gel
digest mass spectrometry. The deer Lf amino acid sequence was obtained from a deer
protein sequence database that was generated from a deer transcriptome analysis under-
taken in-house in the Department of Biochemistry, University of Otago. The combined
sequence coverage of tryptic, chymotryptic, and semi-chymotryptic peptides obtained
was used to interrogate the in-house generated deer database and was found to achieve
65.21% coverage of the Lf amino acid sequence with matched peptides. The amino acid
sequence of deer Lf which was generated from mRNA sequence is shown in Table 1, with
comparison to the amino acid sequence of bovine Lf (PDB ID: 1BLF) [12]. Deer Lf was
found to contain 707 amino acids, which is one amino acid less than the bovine Lf sequence.
The primary structure of deer Lf was found to be 92% homologous with the bovine Lf
sequence, with 55 differences in the amino acid sequence. The amino acid sequence of deer
Lf reported in the present study, shows that it has a molecular weight of 77.1 kDa, that
is lower than bovine Lf (78 kDa), and deer Lf has a slightly higher pI (7.99) than bovine
Lf (7.9) [22].
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MKLFV PALLA LGALG LCLAA PRKNV RWCAI SQPEW SKCYR WQWRM KKLGT PFVTC VRRTS 3




ALECI RAIAA KKADA VTLDS GLVFE AGLDP YKLRP VAAEI YGTEK SPQTH YYAVA VVKKG




SNFQL DQLQG RKSCH TGLGR SAGWN IPIGI LRPSL GWTES LEPLQ GAVAK FFSAS CVPCV




DGKAY PNLCQ LCKGT GENQC ACSPR EPY_G YSGAF RCLQE GAGDV AFVKE TTVFE NLPEK




ADRDQ YELLC LNNSR APVDA FKECH LAQVP SHAVV ARSVD GKEDL IWQLL SKAQE KFGKN




KSQ 5 SF QLFGS PGSQR DLLFK DSALG FLRIP SKIDS ELYLG ARYLT ALKNL RETEE EVKAR




STRVV WCAVG PEEQK KCQQW SQQSD QSVTC ATAST TDDCI ALVLK GEADA LSLDG GYIYT




AGKCG LVPVM AENRK SSKDS SLDCV LRPTE GYLAV AVVKK ANEGL TWNSL KGKKS CHTAV




DRTAG WNIPM GLIAN QTGSC KFDEF FSQSC APGAD PKSSL CALCA GDDQG LDKCV PNTKE




KYYGY TGAFR CLAED VGDVA FVKND TVWEN TNGES SADWA KNLNR EDFRL LCLDG TRKPV




TEAQS CHLAA APSHA VVSRS DRAAH VEQVL LHQQA LFGRN GKDCP DKFCL FKSET KNLLF




NDNTR CLAKL GGRPT YEKYL GTEYV TAIAN LKKCS TSPLL EACAF LTR
NDNTE CLAKL GGRPT YEEYL GTEYV TAIAN LKKCS TSPLL EACAF LTR
Letters in bold indicate differences in the amino acid sequence in deer lactoferrin (Lf) compared to bovine Lf. 1 The amino acid sequence
of bovine Lf was obtained from UniProtKB-P24627. 2 The first 19 amino acids of bovine Lf is signal peptide sequence that is cleaved at
Ala19-Ala20 to yield the mature bovine Lf [7]. The numbering of the peptides below is with respect to the mature Lf sequence. 3 Underlined
deer Lfcin f(17–41). 4 Underlined bovine Lfcin f(17–41). 5 Underlined deer Lfampin f(265–284). 6 Underlined bovine Lfampin f(265–284).
Characteristics of Deer Lactoferricin and Lactoferrampin
Modelled 3-D structures of deer Lfcin and Lfampin were found to be similar to that
of the bovine Lfcin and Lfampin structures (Figure 3). The amino acid sequences of Lfcin
(17–41) from deer and bovine Lf share 72% homology. Deer Lfcin has seven positively
charged amino acids and bovine Lfcin has eight positively charged amino acids. There are
nine hydrophobic residues and nine hydrophilic residues in deer Lfcin. However, bovine
Lfcin has two more hydrophobic residues than deer Lfcin. The high overall positive charge
of peptides with a net charge of at least +4 and hydrophobic residues are reported to be
important for antibacterial activity of bovine Lfcin [23,24]. Deer Lfcin possesses similar
characteristics of positive charge and hydrophobic residues which indicate deer Lfcin
should exhibit antibacterial activity like bovine Lfcin. But due to different numbers of
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positively charged amino acids and hydrophobic residues in deer Lfcin, it might have
differences in binding to the bacterial cell wall, resulting in a difference in activity.
Figure 3. In silico structures of deer and bovine lactoferricin (Lfcin) and lactoferrampin (Lfampin). (A) Structure of
bovine Lfcin (FKCRRWQWRMKKLGAPSITCVRRAF) (PDB ID: 1BLF); (B) Structure of deer Lfcin (SKCYRWQWRMKKL-
GTPFVTCVRRTS) displayed using PyMOL; (C) Structure of bovine Lfampin (265–284) (DLIWKLLSKAQEKFGKNKSR)
(PDB ID: 1BLF); (D) Structure of deer Lfampin (265–284) (DLIWQLLSKAQEKFGKNKSQ) displayed using PyMOL. Pink
squares indicate differences between deer and bovine Lfcin and Lfampin.
Deer and bovine Lfampin are homologous, apart from difference in two different
amino acids, resulting in 90% similarity. Basic amino acids, Lys and Arg, in bovine
Lfampin are replaced with amide amino acids in deer Lfampin. There are four positively
charged amino acids in deer Lfampin and six in bovine Lfampin. Both peptides have seven
hydrophobic residues.
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3.3. Antibacterial Activities of Synthesized Peptides Lactoferricin and Lactoferrampin on
Bacterial Growth
Deer and bovine Lfcin and Lfampin at different concentrations were tested against E.
coli ATCC 25922, S. aureus ATCC 23923, and L. acidophilus ATCC 4356. The MIC of deer
Lfcin against E. coli ATCC 25922 was found to be 240 µg/mL and the MBC was found
to be the same (Table 2). Bovine Lfcin was found to be 120 µg/mL for both the MIC and
the MBC for E. coli ATCC 25922 (Table 2). Deer Lfampin, within the concentration range
from 15 to 480 µg/mL, promoted E. coli ATCC 25922 growth. The MIC, as well as MBC
of bovine Lfampin against E. coli ATCC 25922 was found to be 480 µg/mL. These results
indicate that at an equivalent concentration, bovine Lfcin and Lfampin were more active as
antimicrobial inhibitors of E. coli ATCC 25922 growth than deer Lfcin and Lfampin.
Table 2. Minimum Inhibitory Concentrations (MIC) (µg/mL) of deer and bovine lactoferricin (Lfcin)
and lactoferrampin (Lfampin) against E. coli ATCC 25922, S. aureus ATCC 25923, and L. acidophilus
ATCC 4356. The Minimum Bactericidal Concentrations (MBC) values were found to be the same as
that of the MIC values.
Lfcin Lfampin
Deer Bovine Deer Bovine
E. coli ATCC 25922 240 b 120 a >960 d 480 c
S. aureus ATCC 25923 >960 >960 >960 >960
L. acidophilus ATCC 4356 480 a >960 b >960 b >960 b
a–d means with different superscripts are significantly different at p < 0.05.
Although no MICs were achieved within the tested concentrations (30–480 µg/mL)
for deer or bovine Lfcin and Lfampin against S. aureus ATCC 25923, the lag time and
generation time of S. aureus was found to increase in the presence of deer and bovine Lfcin
at 240 and 480 µg/mL respectively. This indicates that both deer and bovine Lfcin slowed
the growth of S. aureus. The MIC of deer Lfcin against L. acidophilus ATCC 4356 was found
to be 480 µg/mL. At the same concentration, deer Lfcin showed more active antimicrobial
inhibitory ability against L. acidophilus ATCC 4356 than did bovine Lfcin. Deer Lfampin
was also more active against L. acidophilus ATCC 4356 than was bovine Lfampin at the
same concentration, but no MICs were achieved.
The effects of deer Lfcin at 240 µg/mL, bovine Lfcin at 120 µg/mL, and bovine
Lfampin at 480 µg/mL on E. coli ATCC 25922 viability at 0 and 24 h in the antimicrobial
activity tests are shown in Figure 4. Green colored bacterial cells indicate an intact bacterial
membrane, which at 0 h indicate that the bacteria were viable. After 24 h of exposure
to antimicrobial peptide, the E. coli cells exhibited a red color. This indicated that E. coli
ATCC 25922 bacteria were non-viable following exposure to the antimicrobial peptides.
The antibiotics penicillin (10,000 units/mL) and streptomycin (10,000 µg/mL) were used as
controls. Figure 4D shows the E. coli cell viability at 0 and 24 h in the presence of antibiotics.
It can be concluded that these three peptides at their MICs had an equivalent inhibitory
effect on E. coli ATCC 25922 as did the antibiotics.
L. acidophilus ATCC 4356 cell viability in the presence of deer Lfcin at 480 µg/mL at
0 and 24 h was compared with treatment with the antibiotics penicillin (10,000 units/mL)
and streptomycin (10,000 µg/mL), along with an MRS broth control group. Figure 4F
shows most of the L. acidophilus cells were viable (green) with only a few non-viable (red) at
0 h. After 24 h, although the number of bacterial cells increased, most of the bacteria were
found to be non-viable following exposure to deer Lfcin at 480 µg/mL. With the antibiotic
treatment, the bacterial viability at 0 h was the same as that of deer Lfcin in which most of
the bacteria were viable, but at 24 h were non-viable, indicating that the antibiotics were
more effective at inhibiting L. acidophilus growth than was deer Lfcin at 480 µg/mL. In
Figure 4H for the MRSc broth control group, the majority of bacterial cells were viable at 0 h.
After 24 h, there were more bacteria in the field and viable bacterial cells still outnumbered
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non-viable cells. Due to the variable dimensions of L. acidophilus that were observed in the
microscope field, bacterial cell numbers could not be accurately determined.
Figure 4. Cont.
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Figure 4. Bacterial viability determined using the LIVE/DEAD BacLightTM Bacterial viability kit. Incubation with
lactoferricin (Lfcin) and lactoferrampin (Lfampin) at 0 and 24 h. (A) E. coli ATCC 25922 incubated with deer Lfcin
240 µg/mL. (B) E. coli ATCC 25922 incubated with bovine Lfcin 120 µg/mL. (C) E. coli ATCC 25922 incubated with bovine
Lfampin 480 µg/mL. (D) E. coli ATCC 25922 incubated with penicillin (10,000 units/mL) and streptomycin (10,000 µg/mL).
(E) E. coli ATCC 25922 incubated with nutrient broth. (F) L. acidophilus ATCC4356 incubated with deer Lfcin 480 µg/mL.
(G) L. acidophilus ATCC4356 incubated with penicillin (10,000 units/mL) and streptomycin (10,000 µg/mL). (H) L. acidophilus
ATCC4356 incubated with MRSc broth. Green fluorescence indicates viable bacteria, red fluorescence indicates non-viable
bacteria. Microscope magnification ×1000.
4. Discussion
Lfcin, which is located in the N-domain of bovine Lf, can be produced by gastric
pepsin cleavage of Lf [25]. It is a 25-amino-acid peptide that has a high proportion of basic
residues, with a net charge of +8, and amphipathic properties [26]. The ability of Lfcin
to form amphipathic structures with net hydrophobic and positively charged surfaces is
a trait that is shared with other peptides having antimicrobial activity [27]. As Arg can
interact both electrostatically and through multiple hydrogen bonds with the negatively
charged surface of bacteria, it is thought that this amino acid is the most effective target in
antimicrobial peptides to interact with the bacterial membrane [28]. Once this interaction
occurs, the hydrophobic residues interact with the lipophilic portion of the membrane,
becoming embedded into its surface and destabilizing the packing of the membrane
phospholipids. Of the hydrophobic residues present in Lfcin, Trp is clearly important. The
bactericidal activity of bovine Lfcin appears to be dependent on not just one Trp but on
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at least two [23]. Trp acts as an anchor with the bulk of Lfcin residues helping to bind the
peptide to the membrane. The importance of Arg and Trp for the antibacterial activity of
Lfcin highlights the importance of both electrostatic and hydrophobic interactions for the
activity of Lfcin. The in silico modelling of deer Lfcin indicated a very similar α-helical
structure compared to bovine Lfcin. Deer Lfcin has four Arg, one less than bovine Lfcin,
that could interact with the bacterial membrane. One Arg in bovine Lfcin is replaced by Tyr
in deer Lfcin. Both deer and bovine Lfcin have two Trp residues facilitating hydrophobic
interaction with the bacterial membrane. The amino acid sequences predict that deer Lfcin
could have similar antibacterial activity as bovine Lfcin.
Deer Lfampin has the common features of antimicrobial peptides with a high net
positive charge, a hydrophobic domain and hence an amphipathic character. Although
both Lfampin and Lfcin share amphipathic and cationic features, the bactericidal activity
of Lfampin differs from that of Lfcin. Deer Lfampin has a different amino acid composition
and chain length, hence its modelled structure differs somewhat from Lfcin. Bovine
Lfampin is a more recently identified antimicrobial peptide compared to Lfcin and has
been less studied in relation to its mechanism of antimicrobial activity. It has cationic amino
acid residues with the hydrophobic domain containing Trp that is involved in membrane
insertion [14]. The predicted amphipathic helical conformation of this peptide is a common
motif for bioactivity against Gram-positive bacteria [29]. Trp 268 is reported to insert into
the membrane at the lipid/water interface and the phenyl side chain of Phe 278 is oriented
in the same direction as the indole ring of Trp 268, allowing these two residues to anchor
the peptide into the lipid bilayer [29]. The amphipathic N-terminal helix is reported to
anchor bovine Lfampin to the surface of the bacterial membrane with the hydrophobic
side chains of Trp 268 and Phe 278 playing important roles in stabilizing the interaction
and for inducing peptide folding [30]. Deer Lfampin 265–284 has both Trp 268 and Phe
278, which may be involved in membrane insertion during antimicrobial activity. Deer
Lfampin Phe 278 could play an important role of interaction between the peptide and
a negatively charged microbial cell membrane, while the helix capping residues, including
Trp 268, could penetrate into the hydrophobic core of a membrane lipid bilayer.
Bovine Lfcin antimicrobial activity has been reported against E. coli ATCC 25922 within
the range of MIC 3.3 to 30 µg/mL [11]. The variation of MIC of bovine Lfcin against E. coli
could be related to the method used for determining the MIC, different broth, different
strains, and source of Lfcin (pepsin hydrolyzed or chemically synthesized). Previously,
simulated gastrointestinal hydrolysis of un-fractionated hydrolysates conducted in our
laboratory, of deer Lf were found to exhibit differences in antibacterial activity compared to
unfractionated hydrolysates of bovine Lf. In the present study, for synthetic deer Lfcin, the
MIC against E. coli ATCC 25922 was found to be 240 µg/mL which was twice that of bovine
Lfcin MIC in this study. Bovine Lfcin has more positive charged and hydrophobic residues
than deer Lfcin. The difference in amino acid sequences of peptides suggests bovine Lfcin
might have stronger antibacterial activity than deer Lfcin. This assumption was confirmed
by the antimicrobial activity results, that indicated bovine Lfcin was more effective than
deer Lfcin, at the same concentration, against E. coli ATCC 25922. Vorland et al. (1998) found
the antimicrobial activity of bovine Lfcin (MIC 90 µg/mL) was more effective against E.
coli ATCC 25922 than human (MIC > 200 µg/mL), murine (MIC >200 µg/mL), and caprine
(MIC > 200 µg/mL) Lfcins [31]. These Lfcins were in linear form. Cyclic bovine Lfcin
was found to be more active than linear bovine Lfcin against E. coli ATCC 25922 and S.
aureus ATCC 25923. The effect of bovine Lfcin was decreased by reducing the cysteine
disulfides. However, another report studying a fragment of bovine Lfcin consisting of
11 amino acids showed that the disulfide bridge is not essential for activity [32]. The
motif RRWQWR is the minimum described sequence that exhibits antibacterial activity
in bovine Lfcin. This motif is amphipathic, with the hydrophilic face being positive
charged due to the presence of Arg side chains, while the hydrophobic face has Trp side
chains [33]. Also, an even shorter motif RWQWR from bovine Lfcin was reported to exhibit
a high and specific activity against E. coli ATCC 11775 [34]. The (R)RWQWR motif is
Foods 2021, 10, 1305 14 of 16
encrypted in both deer Lfcin (SKCYRWQWRMKKLGTPFVTCVRRTS) and bovine Lfcin
(FKCRRWQWRMKKLGAPSITCVRRAF), which could explain the antimicrobial activity
exhibited by deer Lfcin found in the present study. Deer Lfcin contains positive charged
and hydrophobic amino acid residues which are reported to be important for association
and penetration of the bacterial membrane. More specifically, deer Lfcin contains the
basic amino acid Arg which has the ability to interact with a negatively charged bacterial
membrane, and two Trp that can enhance hydrophobic interaction of the peptide with
a bacterial membrane.
The four peptides, Lfcin and Lfampin from deer and bovine, were not effective against
S. aureus ATCC 25923 within the concentration range from 30 to 480 µg/mL in this study.
It has been reported that the MIC of cyclic and linear bovine Lfcin against S. aureus ATCC
25923 was 30 and 90 µg/mL, respectively [31]. Different bacterial cell density, culture broth,
and peptide structures may explain the different results obtained in the present study.
L. acidophilus ATCC 4356 was chosen as a representative of probiotic bacteria from
human gut microbiota. Deer and bovine Lfcin and Lfampin were tested on L. acidophilus in
order to investigate the effect of these antimicrobial peptides on bacteria which colonize the
human gut. Deer Lfcin at 480 µg/mL reached the MIC against L. acidophilus. The present
study showed the inhibitory activity of deer and bovine Lfcin and Lfampin on L. acidophilus
growth. Chen et al. (2013) found L. acidophilus ATCC 4356 was inhibited by both bovine
Lf and its hydrolysate with MIC 16 mg/mL for 24 h [35]. In the present study, deer and
bovine Lfcin and Lfampin not only inhibited food-pathogenic bacteria (e.g., E. coli and
S. aureus), but also probiotic bacteria.
The plate count method is routinely used in the determination of microbial viability.
It is based upon the premise that a single bacterium can grow and divide to produce
an entire colony. Microbial cells may exist in cryptobiotic, dormant, moribund, or latent
states, in which they will not form colonies on nutrient media but may have other mea-
surable activity [36]. No method exists that demonstrates with absolute certainty whether
an organism is alive or dead. It is argued that the presence of intact and functional nucleic
acids, as well as an intact and polarized cytoplasmic membrane are essential components of
cellular viability. The membrane integrity stain LIVE/DEAD BaclightTM is not a measure
of life or death but assesses particular location-specific damage to cells. Both SYTO9 and PI
stain nucleic acids. Green fluorescent SYTO9 generally labels all bacteria in a population,
both those with intact membranes and those with damaged membranes. In contrast, red
fluorescent PI which is a relatively large (668 Da) and double-charged dye, penetrates
only bacteria with damaged cytoplasmic membranes, causing a reduction in the SYTO9
stain fluorescence when both dyes are present [37]. Thus, with an appropriate mixture
of the SYTO9 and PI stains, bacteria with intact cell membranes stain fluorescent green,
whereas bacteria with damaged membranes stain fluorescent red. The emission properties
of the stain mixture bound to DNA change due to the displacement of SYTO9 by PI and
quenching of SYTO9 emissions by fluorescence resonance energy transfer [38].
In addition to penetrating the cell wall and cell membrane of bacteria, bovine Lfcin
can inhibit bacteria by affecting intracellular activity, by attacking the transcription-related
activities and several cellular carbohydrate biosynthetic processes (DNA, RNA and protein
synthesis), and can ultimately result in cell death in both Gram-negative and Gram-positive
bacteria [39]. The present results of red fluorescence exhibited by E. coli ATCC 25922
and L. acidophilus ATCC 4356 after exposure to antimicrobial peptides for 24 h in the
assays, showed that the bacterial cell membrane was damaged by deer Lfcin at 240 µg/mL,
bovine Lfcin at 120 µg/mL, and bovine Lfampin and deer Lfcin at 480 µg/mL. Trp and
Phe in bovine Lfampin have been reported to damage the integrity of the bacterial cell
membrane [30], which was observed in the present study by the red fluorescence of E. coli
ATCC 25922 treated with bovine Lfampin at 480 µg/mL.
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5. Conclusions
Deer Lf was successfully fractionated from deer milk using cation exchange chromatog-
raphy. Deer Lf was found to have a slightly higher isoelectric point (pI) of
7.99 compared to bovine Lf (pI 7.9). Deer Lf was found to contain 707 amino acids with
a MW 77.1 kDa, with one less amino acid than bovine Lf (78 kDa). The deer Lf sequence
was found to be 92% homologous to that of bovine Lf. Deer Lfcin and Lfampin share 72%
and 90% similarities with bovine Lfcin and Lfampin, respectively. Deer Lfcin, bovine Lfcin
and Lfampin exhibited strong inhibitory activity against E. coli ATCC 25922 with MICs
of 240, 120, and 480 µg/mL respectively. Bovine Lfcin and Lfampin exhibited stronger
antimicrobial activity than deer Lfcin and Lfampin against E. coli ATCC 25922 at the same
concentrations. The MIC of deer Lfcin against L. acidophilus ATCC 4356 was 480 µg/mL
in the present study. L. acidophilus ATCC 4356 was more susceptible to inhibition by deer
Lfcin than bovine Lfcin. Although both deer Lfcin and Lfampin have amphipathic and
cationic features, the antibacterial activities differ from that of bovine Lfcin and Lfampin,
respectively, likely because they have different numbers of positive charged and hydropho-
bic residues which play important roles in the binding and penetration of the bacterial
membrane in eliciting the antimicrobial activity.
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